Why the U.S. lags in approving a nasal Covid vaccine
Foreign rivals are developing nasal vaccines that could stop Covid transmission and a U.S. company invented the nasal vaccine that an Indian drugmaker licensed. But in the United States, Congress can’t agree on how to pay for additional money to fund next-generation Covid vaccines. Carmen Paun about her reporting with Megan Messerly. Plus, Dr. David Curiel on developing the nasal Covid-19 vaccine that Indian drugmaker Bharat Biotech has licensed.
Audio is streamed directly from the publisher (traffic.megaphone.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Foreign rivals are developing nasal vaccines that could stop Covid transmission and a U.S. company invented the nasal vaccine that an Indian drugmaker licensed. But in the United States, Congress can’t agree on how to pay for additional money to fund next-generation Covid vaccines. Carmen Paun about her reporting with Megan Messerly. Plus, Dr. David Curiel on developing the nasal Covid-19 vaccine that Indian drugmaker Bharat Biotech has licensed.
Learn more about your ad choices. Visit megaphone.fm/adchoices